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Dual Inhibition of Sister Chromatid
Separation at Metaphase
the anaphase promoting complex (APC) (for review, see
King et al., 1996a). This proteolysis pathway is under
the control of the mitotic spindle checkpoint, which ties
Olaf Stemmann,1,4 Hui Zou,1,4 Scott A. Gerber,1,2
Steven P. Gygi,1,2 and Marc W. Kirschner1,3
1 Department of Cell Biology
2 Taplin Biological Mass Spectrometry Facility the separation of sister chromatids to the successful
assembly of the mitotic spindle.Harvard Medical School
Boston, Massachusetts 02115 Securin binding is unlikely to be the only mechanism
that inhibits separase before anaphase. In fact, when
securin is deleted in yeast, sister chromatids separate
with normal kinetics (Alexandru et al., 1999). Further-Summary
more, securin knockout mice are viable (Mei et al., 2001;
Wang et al., 2001), and human cells lacking securinSeparation of sister chromatids in anaphase is medi-
ated by separase, an endopeptidase that cleaves the undergo a largely normal anaphase (Jallepalli et al.,
2001). Significantly, in the absence of securin, sisterchromosomal cohesin SCC1. Separase is inhibited by
securin, which is degraded at the metaphase-ana- chromatid separation does not occur when cells are
arrested at metaphase, suggesting that the checkpointphase transition. Using Xenopus egg extracts, we
demonstrate that high CDC2 activity inhibits anaphase is still operable (Jallepalli et al., 2001). Securin degrada-
tion can thus not be the only event that is inhibited bybut not securin degradation. We show that separase is
kept inactive under these conditions by a mechanism the activated checkpoint. Taken together, these studies
suggest that additional mechanisms must exist to regu-independent of binding to securin. Mutation of a single
phosphorylation site on separase relieves the inhibi- late sister chromatid separation.
In this report, we demonstrate that separase activitytion and rescues chromatid separation in extracts with
high CDC2 activity. Using quantitative mass spectrom- is inhibited by two independent processes, both acting
on separase itself. One pathway is dependent on se-etry, we show that, in intact cells, there is complete
phosphorylation of this site in metaphase and signifi- curin. The second pathway depends on inhibitory phos-
phorylation of separase, and may account for the appar-cant dephosphorylation in anaphase. We propose that
separase activation at the metaphase-anaphase tran- ent normal separation of chromatids in the absence of
securin.sition requires the removal of both securin and an
inhibitory phosphate.
Results
Introduction
High CDC2 Activity Inhibits Anaphase and Sister
Sister chromatid cohesion is mediated by a multiprotein Chromatid Separation in Xenopus
complex, cohesin (Guacci et al., 1997; Michaelis et al., Egg Extracts
1997). In vertebrates, the majority of cohesin dissociates We have reinvestigated the effect of CDC2 activity on
from chromosomes at prophase (Losada et al., 1998). sister chromatid separation and segregation, using Xen-
Nonetheless, sister chromatid cohesion is maintained opus egg extracts (Shamu and Murray, 1992). It was
in centromeric regions by remaining cohesin complexes originally reported that nondegradable cyclinB1 lacking
(Waizenegger et al., 2000). At the metaphase to ana- the N-terminal 90 amino acids including the destruction
phase transition, the residual cohesin complexes are box (90) prevents a mitotic exit and causes a stable
removed via the cleavage of the cohesin subunit SCC1 arrest in late anaphase (Holloway et al., 1993). When we
by a cysteine endopeptidase, separase. This cleavage returned to this assay, we were surprised to find that
is both sufficient and necessary for the separation of the system was very sensitive to the amount of 90 that
sister chromatids (Uhlmann et al., 1999, 2000; Waizeneg- was added. As reported by Holloway et al. (1993), we
ger et al., 2000). Therefore, regulation of separase is found that mitotic exit, as judged by spindle disassembly
of prime importance for the temporal control of sister and chromosome decondensation, was blocked at a
chromatid separation. 90 concentration of at least 40 nM (Figure 1A, columns
The timing of sister chromatid separation is linked to 3 and 4). At this concentration, and up to 80 nM, ana-
the mitotic cell cycle by the destruction of an anaphase phase occurred efficiently (Figure 1A, rows 4 and 5).
inhibitor, securin. Securin was identified in yeast (Yama- However, at a 90 concentration of 120 nM and above,
moto et al., 1996), and its functional homologs, which not only was mitotic exit prevented, but anaphase was
are widely divergent in sequence, were later found in also completely suppressed. Even 50 min after initiation
higher eukaryotes (Zou et al., 1999; Leismann et al., of anaphase, most spindles were still in a metaphase-
2000). Before anaphase, securin forms a complex with like configuration (Figure 1A, rows 6 to 8). This effect
separase and presumably inhibits its activity (Ciosk et was not a peculiarity of our particular 90 preparation.
al., 1998; Zou et al., 1999). At anaphase, securin is de- In most of our experiments, we used human 90 ex-
graded by ubiquitin-dependent proteolysis mediated by pressed in insect cells, but bacterially expressed sea
urchin 90 caused the same inhibition phenotype (data
not shown). Though demonstrating that a small (less3 Correspondence: marc@hms.harvard.edu
4 These authors made equal contributions to this work. than 2-fold) increase in 90 could change the terminal
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Figure 1. High CDC2/cyclinB1 Activity Inhibits Sister Chromatid Separation and Segregation in Xenopus Extracts but Not Securin Degradation
(A) Effects of nondegradable cyclinB1 (90) and the CDC2 inhibitor roscovitine on anaphase and mitotic exit. CSF-arrested Xenopus egg
extracts supplemented with rhodamine-tubulin and Xenopus sperm nuclei were cycled through interphase and rearrested at metaphase. 90
and roscovitine were added at 25 min and 10 min, respectively, before the addition of Ca2. To evaluate anaphase occurrence, whole spindles
and individual chromosomes were visualized by fluorescence microscopy. Spindle disassembly and chromosome decondensation were used
as readout for mitotic exit. Note that sister chromatid separation and segregation did actually occur at 0 and 20 nM 90 but were not evaluated,
because 50 min after calcium addition, these extracts had long exited mitosis.
(B) Histone H1 kinase assay for selected extracts as used in (A).
(C) APC is not inhibited by high-90 concentrations. 35S-labeled Xenopus securin and an N-terminal fragment of cyclinB1 were generated by
in vitro translation and added to CSF-extracts. The kinetics of securin degradation after Ca2 addition were measured in the presence (500
nM) or absence of human 90 (upper panel). In the lower panel, degradation of cyclinB1 was detected 45 min after Ca2 addition. The extract
contained 32 to 500 nM human 90 (lanes 2 to 6; 2-fold increase in concentration between each lane), 82 to 1300 nM sea urchin 90 (lanes
7 to 11), or 50 to 800 nM unlabeled cyclinB1 fragment (lanes 12 to 16). Lane 1: Negative control without Ca2 addition.
arrest phenotype, these observations did not clarify We conclude that two different concentration ranges
of nondegradable cyclinB1 cause two different effects.whether the spindles failed to move chromosomes to-
ward the poles or whether the anaphase block was ac- At the lower concentration range (40 to 80 nM), sister
chromatid separation and segregation occur efficiently,companied by a failure to dissolve sister chromatid co-
hesion. To address this issue, chromosomes were but mitotic exit is blocked; at the higher concentration
range (above 120 nM), sister separation, and hence seg-reisolated from extracts 50 min after the initiation of
anaphase and visualized by fluorescence microscopy regation, are inhibited as well. It is important to note
that90 completely blocks anaphase at a concentrationat high magnification (Funabiki and Murray, 2000). This
analysis revealed that at a 90 concentration of 40 to only 3-fold higher than the minimal concentration neces-
sary to prevent spindle disassembly and chromosome80 nM, almost all chromosomes displayed a one-chro-
matid configuration, indicating that sister separation decondensation.
The most trivial explanation for the inhibition of ana-had taken place (Figure 1A, rows 4 and 5). In contrast,
at a 90 concentration of 120 nM and above, most chro- phase by 90 would be if 90—despite missing the
destruction box—was still a poor APC substrate. In thismosomes displayed a butterfly-like shape characteristic
of chromosomes composed of two unseparated chro- case, it might compete for securin degradation at high
concentrations. To test this possibility, we comparedmatids (Figure 1A, rows 6 to 8).
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the degradation of 35S-labeled securin in extracts lacking
90 or containing it at a very high concentration
(500 nM). The kinetics of degradation in both extracts
were very similar (Figure 1C, upper panel). We also
tested whether different 90 preparations could inhibit
the degradation of an N-terminal fragment of cyclinB1,
another well-documented APC substrate (Glotzer et al.,
1991; King et al., 1996b). Human or sea urchin 90 did
not compete for the degradation of the 35S-labeled frag-
ment, while an unlabeled fragment did so efficiently (Fig-
ure 1C, lower panel). We conclude that 90 is neither
an APC substrate nor an APC inhibitor, and therefore
must inhibit anaphase by a mechanism other than com-
petitive inhibition of securin degradation.
Next, we used a specific CDC2 inhibitor, roscovitine,
to ask whether 90 exerts its inhibitory effect by activat-
ing CDC2 or via an as yet unknown function. When
chromatid separation and segregation were blocked in
a high-90 extract, addition of roscovitine rescued both
events with high efficiency (Figure 1A, row 9). At the
same time, roscovitine reduced the CDC2 activity to the
level of a low-90 extract, as determined by histone H1
kinase assay (Figure 1B). This experiment demonstrated
that nondegradable cyclinB1 acts by activating CDC2
Figure 2. Separase Activity Is Inhibited by High-90 Extractsand further that high CDC2 activity blocks sister chroma-
(A) An in vitro separase activity assay. Tagged separase and associ-tid separation in vitro.
ated securin were affinity-purified from nocodazole-arrested 293T
cells. The left panel shows Western blots of isolated securin/separ-High CDC2 Activity Inhibits Separase Activity ase complexes before (lanes 1 and 2) and after (lanes 3 and 4)
in Xenopus Egg Extracts incubation with low-90 extract. Separase was reisolated, eluted,
The above results suggested that high CDC2 activity and assayed for cohesinhSCC1 cleavage activity. In vitro translated,
radiolabeled cohesinhSCC1 (lanes 5 and 6) or endogenous cohesinhSCC1might block the activity of separase. Alternatively, CDC2
on purified metaphase chromosomes (lanes 7 and 8) served asmight act in a different manner, for example by rendering
substrates. CohesinhSCC1 and its cleavage fragments were detectedthe cohesinhSCC1subunit of cohesin resistant to cleavage.
by autoradiography or anti-cohesinhSCC1 immunoblot, respectively.To address this issue, we developed an in vitro separase The assay was performed with wild-type separase (WT; lanes 1, 3,
activity assay. Plasmids coding for human securin and 5, and 7) and a catalytically inactive separase mutant (C  S; lanes
tagged human separase were transfected into 293T 2, 4, 6, and 8).
(B) Separase activity is inhibited by high-90 extracts. Shown arecells. After arrest in metaphase, the cells were lysed
Western blots with anti-separase (upper left panel), anti-securinand separase was isolated via its affinity tag. Separase
(lower left panel), and anti-cohesinhSCC1 (right panel) antibodies. Thewas associated with its inhibitor securin and inactive at
assay was performed essentially as described above.this stage (Figure 2A, lane 1 and data not shown). When
the complex was incubated in a low-90 extract, securin
was degraded (Figure 2A, compare lanes 1 and 3). At high-90 extract (Figure 2B, lanes 2 and 5). Securin
was degraded under both high- and low-90 conditionsthe same time, separase was cleaved, resulting in two
fragments migrating at 175 and 55 kDa (Figure 2A, lane (Figure 2B, lanes 1 and 2), demonstrating once more
that APC is active in a high-90 extract. In contrast,3 and data not shown). This cleavage of separase is a
characteristic of anaphase and occurs in vivo as well securin was readily detected when APC is inhibited in
a CSF extract (Figure 2B, lane 3). Inhibition of APC isas in vitro (Waizenegger et al., 2000; H.Z., O.S., and
M.W.K., unpublished data). A mutant separase, in which therefore not the reason for the inactivation of separase
in a high-90 extract. Taken together, these experimentsthe catalytic cysteine residue was replaced by a serine,
was not cleaved under the same conditions (Figure 2A, demonstrate that in extracts with high CDC2 activity,
separase is kept inactive despite the absence of securin,lane 4). As the active site lies far from where cleavage
occurs, this result implies that the cleavage of separase thus providing one possible explanation for the block
of anaphase under these conditions.is autocatalyzed (H.Z., O.S., and M.W.K., unpublished
data). Self-cleavage of separase thus serves as a read- We noticed that in some cases, a fraction of separase
was already cleaved initially, despite being fully inhib-out for separase activity. Reisolation of securin-free sep-
arase from the Xenopus extract yielded a preparation ited, as measured by the activity assay. As the same
degree of cleavage was detectable already in crudethat cleaved cohesinhSCC1 efficiently (Figure 2A, lanes 5
to 8). This activity assay put us in a position to ask extracts, we assume that it occurred during synchroni-
zation of the cells. Cleavage to different extents waswhether high-90 extract had any impact on separase
activity. As seen before, separase cleaved itself and observed even for endogenous separase in untrans-
fected cells (data not shown). The reason for these varia-cohesin effectively when treated with a low-90 extract
(Figure 2B, lanes 1 and 4). Interestingly, both cleavage tions is not known but may indicate that self-cleaved
separase can be reinhibited (see below).events were largely suppressed upon incubation in a
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Figure 3. Purification of the Securin/Separase Complex from Nocodazole-Arrested HeLaS3 Cells
(A) Purification scheme and chromatograph of the final purification step. A bracket indicates the elution position of the securin/separase
complex (fractions 5 and 6).
(B) Western blots using both anti-separase (upper panel) and anti-securin (lower panel) antibodies.
(C) Silver staining of the proteins in Mini Q fractions 1 to 9.
(D) Separase activity assay. In this modified assay, 2 l of each Mini Q fraction was combined with 10 l of a low-90 extract and 2 l of in
vitro translated 35S-cohesinhSCC1. After incubation for 1 hr at room temperature and 1 hr at 37C, 2 l of each reaction was analyzed by SDS-
PAGE and autoradiography. Molecular weights in kDa are marked on the left side of the pictures shown in (A), (B), and (C).
Phosphopeptide Mapping of Separase unphosphorylated peptides. In this way we identified 8
Ser/Thr-phosphorylation sites for separase, all of whichThe inactivity of separase in extracts with high CDC2
activity suggested that separase might be negatively lie in the C-terminal half of the protein (Figure 4A and
data not shown). Phosphorylation site 2 turned out toregulated by phosphorylation. To test this model, we
purified the endogenous securin/separase complex be most important in regulating the activity of separase
(see below). It was identified on two peptides of differentfrom metaphase-arrested HeLaS3 cells and mapped the
phosphorylation sites by mass spectrometry. Western length but spanning the same region (Glu1115 to
Lys1130 and Gly1117 to Lys1130). In both cases, theblots of the last purification step demonstrated that sep-
arase eluted together with securin (Figure 3B). Separase analysis of the y- and b-ion fragmentation series re-
vealed the presence of a phosphate group at Ser1126.and securin were among the few proteins that were
detectable in this preparation by silver staining (Figure As an example, the MS/MS-spectrum of the shorter pho-
sphopeptide is shown in Figure 4A. We also found3C). No other major component seemed to cofractionate
with separase and securin. As expected, the securin/ Ser165 of securin to be phosphorylated (data not
shown).separase-containing fractions cleaved 35S-labeled cohes-
inhSCC1 only after securin was degraded by incubation
with a low-90 extract (Figure 3D and data not shown). Separase Is Regulated by Inhibitory
PhosphorylationAfter preparative SDS-Page and Coomassie staining,
full-length separase and securin were cut from the gel, We mutated all eight phosphorylation sites on separase
to alanine, two at a time. The resulting phosphomutantstrypsin digested, and analyzed by LC-MS/MS. Phos-
phate-containing peptides were identified by a differen- (PMs) were named according to the relative positions
of the sites (Figure 4A). They were expressed, purified,tial mass of 80 Da relative to the theoretical mass of
Inhibitory Phosphorylation of Separase
719
Figure 4. Separase Is Inhibited by Direct Phosphorylation at One Major Site
(A) Mass spectrometric determination of phosphorylation sites on separase. The relative positions of the mapped sites on separase are
illustrated on the left side. These sites correspond to Ser1073, -1126, -1305, -1501, -1508, -1545, and -1552 and Thr1346. Shown on the right
is the tandem mass (MS/MS) spectrum of a phosphopeptide derived by collision-induced dissociation of the (M2H)2 precursor, m/z 724.
Fragment ions in the spectrum represent mainly single-event preferential cleavage of the peptide bonds resulting in the sequence information
recorded simultaneously from both the N- and C termini (b- and y-type ions, respectively) of the peptide. This spectrum was computer-
searched with the Sequest program (Eng et al., 1994) and was matched to a separase peptide with additional mass from a phosphate residue
(sequence shown on the left side). With four potential sites of phosphorylation (three serines and one threonine), the correct assignment
(Ser1126) was unambiguously determined based on the presence of ions derived by cleavage at the serine-serine peptide bond. This resulted
in a b9 (826 m/z) and y5 (624 m/z, 544 [peptide]  80 [phosphate]).
(B) Functional identification of the inhibitory phosphorylation site(s). Mutant separases (PMs), which had the serine and/or threonine sites
changed to alanine, were analyzed by the separase activity assay. Numbers indicate which phosphorylation site/sites was/were changed in
each PM mutant. As controls, wild-type separase (WT) and catalytic inactive separase (C  S) were also included. Each mutant was incubated
in either low-90 (odd numbered lanes) or high-90 (even numbered lanes) extract before analyzing separase self-cleavage by immunoblot
(top panels) and cohesinhSCC1 cleavage by autoradiography (middle and lower panels). Even when treated with low-90 extracts, the separase
activities of PM-2/4, PM-2, and—to a lesser extent—PM-4 are higher than that of wild-type separase (compare lanes 17, 19, and 21 with lane
15), suggesting the existence of a basal level of inhibitory phosphorylation in low-90 extracts.
and tested for separase activity by our standard assay. (Figure 4B, lanes 19 and 20). PM-4, on the other hand,
was inactivated by high CDC2 activity, albeit less soAs seen above, wild-type separase cleaved itself and
cohesinhSCC1 efficiently at low but not at high CDC2 activ- than wild-type separase (Figure 4B, lanes 21 and 22).
These results demonstrate that in vitro inhibition ofity (Figure 4B, lanes 1, 2, 15, and 16). PM-1/3, -5/6, and
-7/8 behaved like wild-type separase (Figure 4B, lanes separase in the absence of securin is due to phosphory-
lation of separase at one major site (Ser1126). This site3, 4, 7, 8, 11, and 12 and data not shown). Interestingly,
PM-2/4 was no longer inhibited by incubation in extracts resides roughly in the middle of the 233 kDa protease,
far away from the catalytic residue (Cys2029). Mutationwith high CDC2 activity; it cleaved itself and cohesinhSCC1
equally well under conditions of either low or high level of Ser1126 to aspartate could not mimic phosphoryla-
tion. PM-2Asp was not constitutively inhibited (Figure 4B,of 90 (Figure 4B, lanes 5, 6, 17, and 18). To find out
about the relative contributions of sites 2 and 4, we compare lanes 15 and 23), but instead was still largely
resistant to inactivation by a high-90 extract (Figuregenerated single site mutants. PM-2 behaved essentially
like PM-2/4 and was still largely resistant to inhibition 4B, lane 24).
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tion of separase alone is sufficient to rescue sister chro-
matid separation in an extract with high CDC2 activity.
The negative effect of a high-90 extract on sister sepa-
ration therefore seems to be mediated mostly, if not
exclusively, by the inhibition of separase. Based on the
above results, we can exclude the caveat that cohes-
inhSCC1 might be rendered resistant to cleavage in an
extract with high CDC2 activity.
A second mutant, PM-4, caused some loss of cohe-
sion, albeit less than PM-2 (38% versus 68%; Figure 5A,
rows 5 and 6). When the amount of added separase was
reduced, the difference between PM-2 and -4 became
more pronounced and resembled more closely the situa-
tion of the cohesinhSCC1 cleavage assay (Figure 4B and
data not shown). Thus, phosphorylation site 4 (Thr1346)
seems to have a minor effect on separase activity, while
Ser1126 appears to be the major regulatory site.
Separase Ser1126 Is Quantitatively Phosphorylated
in Metaphase Cells and Becomes Partly
Dephosphorylated upon Anaphase Onset
If the inhibitory phosphorylation of separase occurs in
vivo parallel to the inhibition by securin binding, one
would predict that (1) in metaphase, a considerable frac-
Figure 5. Sister Chromatid Separation in High-90 Extract Can Be tion of separase is phosphorylated at Ser1126 and (2)
Rescued by a Single Point Mutation in Separase
the phosphorylation state at the inhibitory site de-
(A) Mutation of Ser1126 in separase restores sister chromatid sepa-
creases upon anaphase onset.ration in the presence of high CDC2 activity. Separation of human
Using a quantitative mass spectrometry technique,sister chromatids was assayed in high-90 (400 nM) extract in the
we quantified the phosphorylation of separase in syn-presence of either wild-type separase or various separase mutants
(supplied as purified securin/separase complexes). Reisolated chro- chronized cells. To this end, extracted peptides from
mosomes were stained with DAPI (blue) and CREST serum (red) in-gel digested separase were combined with a constant
and analyzed by fluorescence microscopy. ratio of the synthetic, isotopically labeled phosphory-
(B) Anti-separase Western blot. The amounts of separase used in
lated and unphosphorylated tryptic peptides Glu1115-the sister chromatid separation assay (A) were compared to each
Lys1130 (spanning Ser1126). These internal standardsother by immunoblotting.
had the same sequence and therefore the same chemi-
cal properties as the native peptides but carried a heavy,
13C/15N-labeled leucine that increased their mass by 7A Single-Site Phosphomutant of Separase
Is Sufficient to Rescue Sister Chromatid Da relative to the native (light) peptides in the samples.
Phosphorylated and unphosphorylated peptide levelsSeparation in a High-90 Extract
We asked further whether the PM-2 mutant would over- could thereby be accurately determined by LC-MS/MS
and compared between each sample. For transfectedride the inhibition not only of cohesin cleavage but also
of sister chromatid separation in high-90 extracts. 293T cells, we found that 54 (0.9)% of affinity-purified
separase was phosphorylated at Ser1126 in nocoda-Since the biochemical experiments utilized human sep-
arase, we modified the existing assay to examine the zole. 125 min after release from nocodazole, the level
of phosphorylation dropped to 30 (0.9)% (data notseparation of human metaphase chromosomes in Xeno-
pus extracts. The maximal degree of sister chromatid shown). Although affinity purification of separase gave
extremely clean peptide spectra, the transfection exper-separation that was observed in this system under opti-
mal conditions (low-90 extract plus saturating level of iment had the disadvantage that it involved high overex-
pression of separase and that the synchronization ofPM-2/4) was about 70% (data not shown). In the pres-
ence of wild-type separase and high concentrations of the cells was less efficient. We therefore asked whether
we could also measure phosphorylation of peptide90, only 2.7% of the chromosomes separated (Figure
5A, row 2). Likewise, separation was negligible when Glu1115-Lys1130 under more physiological conditions
and with as little manipulation as possible (i.e., withcatalytically inactive separase was added (0.4%) or
when separase was omitted (1.4%; Figure 5A, rows 1 no purification of separase). Crude high speed extracts
from synchronized, untransfected HeLaS3 cells wereand 3). In contrast, PM-2 led to maximal separation
of sister chromatids (68%) under the same conditions directly submitted to SDS-PAGE and the regions, where
full-length separase and its N-terminal cleavage frag-(Figure 5A, row 5). Similar results were obtained with
PM-2/4 and PM-2Asp; they caused 68% and 66% separa- ment migrated as judged by Western blotting, were cut
from the gel. Because separase underwent self-cleav-tion, respectively (Figure 5A, rows 4 and 7). A Western
blot for separase was performed to assure that similar age upon release from nocodazole arrest (Figure 6A),
both gel pieces of each time point were pooled andamounts of the various separases had been used in the
experiment (Figure 5B). analyzed as described above. Remarkably, in using this
technique, the Glu1115-Lys1130 peptides of endoge-We conclude that preventing inhibitory phosphoryla-
Inhibitory Phosphorylation of Separase
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Figure 6. The Inhibitory Phosphorylation of Separase Is High in Metaphase and Declines upon Anaphase Onset
(A) FACS and Western analysis of synchronized HeLaS3 cells undergoing mitosis.
(B) Quantification of cell cycle distribution and phosphorylation status of separase at Ser1126 for the samples shown in (A).
(C) Nano-scale microcapillary LC-MS/MS analysis of native separase phosphorylation state. Crude cell extracts (0.4 mg) were subjected to SDS-
PAGE, and separase was analyzed as described (see Experimental Procedures). Shown are the selected reaction, extracted ion chromatograms
corresponding to the unphosphorylated (upper trace) and phosphorylated (bottom trace) Glu1115-Lys1130 native tryptic peptide (blue and
green) and 150 fmol of heavy internal standard (brown and red). Inset: Averaged selected reaction m/z window corresponding to the y10-ion
fragment of light and heavy peptides. Within 110 min of release (bottom panel) from nocodazole arrest (top panel), the ratio of phosphorylated
to unphosphorylated peptide dropped 5-fold.
(D) Ser1126-specific in vitro kinase assays. Shown is the phosphorylation status of Ser1126 in percent as determined by incubation of affinity-
purified securin/separase with various pure kinases in the presence of ATP (1 mM) followed by LC-MS/MS analysis.
(E) LC-MS/MS result for CDC2/cyclinB1. Top panel: Mock treatment. The phosphorylation state of Ser1126 in separase was 34%. Bottom
panel: CDC2/cyclinB1. 88% of separase was phosphorylated. Internal standard was present at 50 fmol.
nous separase could readily be detected from 0.4 mg of phosphorylation was indeed accurately determined
from crude extracts. Given the fact that the arrest wastotal cell lysate. The analysis revealed that in metaphase,
91% of Ser1126 was phosphorylated (Figures 6B and not perfect (85% G2/M as determined by ModFit soft-
ware), these results strongly suggest that in metaphase,6C). Immunoprecipitation of separase prior to the SDS-
PAGE gave a very similar result (93% phosphorylation; separase is quantitatively phosphorylated. Analysis of
the other cell cycle states revealed that in S-phase, 35%data not shown), thereby confirming that the degree
Cell
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of Ser1126 carried a phosphate residue. More impor- mechanisms can operate independently of one another.
The experiments also showed that separase that is al-tantly, 80 min after release from nocodazole, only 79%
of separase remained phosphorylated, and this level ready active can be reinhibited by either of the two
inhibitory events. In the case of phosphorylation, it re-dropped further to 67% at 110 min (Figures 6B and 6C).
This change corresponds to a 5-fold decrease in the mains to be determined if the reinhibition of cleaved
separase is as efficient as for uncleaved separase.ratio of phosphorylated to unphosphorylated peptide.
Considering that even at the 110 min time point, 40% We also compared how efficiently wild-type and mu-
tant separase were inhibited by securin. When wild-typeof the cells were still in mitosis as determined by FACS
analysis (Figures 6A and 6B), these values represent separase and PM-2/4 were used in equal amounts, as
judged by anti-separase Western blot (Figure 4B, lanesapproximately a 2-fold underestimation of the actual
extent of dephosphorylation upon exit from mitosis. 15 and 17), both were inhibited at the same concentra-
tion of securin (Figure 6B). Thus, wild-type separase andOverall, the relative change in the phosphorylation sta-
tus of Ser1126 coincided well with the relative change the PM-2/4 mutant bind securin with similar affinities.
This supports the notion that PM-2/4 is active in a high-of the cyclinB1 level (compare Figures 6A and 6B). In
summary, these experiments demonstrated that separ- 90 extract because it is no longer phosphorylated and
not because it binds any residual securin, which mightase becomes fully phosphorylated at its inhibitory site
when cells are arrested in mitosis and that this phos- have escaped degradation, with much lower affinity.
phate group is removed from a considerable fraction of
separase as cells undergo anaphase. Discussion
As shown by Nasmyth and coworkers in yeast and byCDC2/cyclinB1 and MAP-Kinase Efficiently
Phosphorylate Ser1126 In Vitro Murray and colleagues in Xenopus egg extracts, nonde-
gradable cyclinB1 at a certain level blocks exit fromWe also used quantitative mass spectrometry with iso-
topically labeled peptides to determine which kinase is mitosis but not the induction of anaphase (Holloway et
al., 1993; Surana et al., 1993, Irniger et al., 1995). Theseable to phosphorylate separase in vitro at its inhibitory
site. As a substrate, we used overexpressed securin/ important studies proposed for the first time the exis-
tence of an anaphase inhibitor, which was degraded byseparase purified from transfected, unsynchronized
293T cells. Ser1126 was efficiently phosphorylated by the same ubiquitin-dependent pathway as cyclinB1. The
discovery of securin in yeast and later in higher eukary-both CDC2/cyclinB1 and MAPK (ERK2) but not at all
by CaMKII (calmodulin-dependent kinase II), polo, or otes fulfilled this prediction (Funabiki et al., 1996; Leis-
mann et al., 2000; Yamamoto et al., 1996; Zou et al.,auroraA (Figures 6D and 6E). As controls, we found that
auroraA phosphorylated myelin basic protein and that 1999). In this paper, we extend these findings to obtain
a more complete picture for the control of anaphaseCaMKII and polo underwent efficient autophosphoryla-
tion (data not shown). onset in vertebrates. Using Xenopus egg extracts to
recapitulate anaphase in vitro, we discovered that CDC2
not only prevents mitotic exit but also blocks the dissolu-Both Securin Binding and Phosphorylation Can
tion of sister chromatid cohesion. This inhibition is dueIndependently Inhibit Separase
to the inactivation of separase by phosphorylation at oneWe have shown that separase activity can be blocked
major site. Mutation of the respective serine to alanine isby phosphorylation when securin is not present. But can
sufficient to render both the cleavage of cohesinhSCC1securin inhibit separase independent of the phosphory-
by separase and the separation of sister chromatidslation state of separase? And can separase that has
resistant to high CDC2 activity. In vivo, the inhibitoryalready been activated and has therefore cleaved itself
site of separase is quantitatively phosphorylated atbe reinhibited by any of the two inhibitory mechanisms?
metaphase arrest and becomes partly dephosphory-To address these questions, we first generated active
lated upon release into anaphase.separase by treating a securin/separase complex with a
low-90 extract. The fact that separase had completely
cleaved itself after this treatment demonstrated that it A Revised Model for Sister Chromatid Separation
Our results suggest an extended model of sister chro-was indeed active at this state (data not shown). Active
separase was then incubated with either recombinant matid separation in vertebrates as shown in Figure 7C.
Before anaphase onset, separase is subject to a 2-foldsecurin or a high-90 extract and assayed for its ability
to cleave cohesinhSCC1. Figure 7 illustrates that securin inhibition: on one hand, there is the established inhibi-
tion of separase by association with the inhibitor securin;and a high-90 extract each caused reinhibition of sep-
arase activity, although the reinhibition by phosphoryla- on the other hand, there is a hitherto unknown inhibitory
phosphorylation, which is due to the high CDC2/tion was less complete (Figure 7A, lane 3; Figure 7B,
lanes 2 and 3). Approximately a 2.5-fold molar excess cyclinB1 activity at this stage of the cell cycle. According
to this model, securin degradation on its own is notof recombinant securin was sufficient to fully suppress
cohesinhSCC1 cleavage (Figure 6B). The respective control sufficient to activate separase. Before sister chromatid
separation can take place, the inhibitory phosphoryla-treatments left separase active (Figure 6A, lane 1; Figure
6B, lane 1). Likewise, separase did not become active tion has to be removed as well.
One scenario of how this might happen is that APCwhen consecutively treated with high-90 extract twice
(Figure 6A, lane 2). causes destruction of a part of cyclinB1, thereby causing
a drop in CDC2 activity. This would allow a putative,In summary, separase can be inhibited by either se-
curin or an extract with high CDC2 activity, and these constitutively active phosphatase to gain the upper
Inhibitory Phosphorylation of Separase
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Figure 7. Independent Inhibition of the Sep-
arase Activity by Phosphorylation of Sepa-
rase and by Binding of Securin
(A) Phosphorylation can largely inactivate
separase that has already been active. Immu-
nopurified securin/separase complex was in-
cubated in low-90 extract (L) to degrade
securin and dephosphorylate separase. Ac-
tive separase on beads was then incubated
in high-90 extract (H; lane 3) or again in low-
90 extract (positive control, lane 1). After
elution, separase was detected by Western
blot (upper panel) and cohesinhSCC1 cleavage
activity was measured by using isolated chro-
mosomes as substrate (lower panel). Lane 2:
Consecutive treatment of separase with high-
90 extract twice.
(B) Active separase is reinhibited by associa-
tion with securin. Separase that had been
preactivated in low-90 extract was eluted
and incubated with recombinant securin
(lanes 2 and 3) or reference buffer (lane 1) for
one hour on ice. Subsequently, its cleavage
activity toward in vitro translated 35S-cohes-
inhSCC1 was tested (upper panel). The separase
concentration in each reaction was 4 nM, as
estimated by Coomassie staining. To com-
pare wild-type separase with PM-2/4 mutant
separase in its ability to bind securin, the
same experiment was repeated with PM-2/4
(lower panel). Roughly equal separase con-
centrations in both cases were assured by
comparative immunoblotting (see Figure 4B,
lanes 15 and 17).
(C) A model for the dual inhibition of separase
in metaphase and its activation at anaphase
onset. PPase denotes an unknown protein
phosphatase that is proposed to act on phos-
phorylated separase.
hand, which would result in dephosphorylation and acti- did not detect a complete dephosphorylation of sepa-
rase upon release from nocodazole. Alternatively, thevation of separase. Several observations support this
explanation. In Xenopus extracts, histone H1 kinase ac- postulated phosphatase (see above) might be indepen-
dently regulated and become active at the metaphase-tivity drops to interphase level before anaphase be-
comes visible (Shamu and Murray, 1992). Likewise, it anaphase transition. In this case it might dephosphory-
late separase, despite a lack of cyclinB1 degradation.has been reported in mammalian cells that cyclinB1
destruction commences about 25 min before anaphase
onset. During the same period of time, cyclinB1, which Is Separase Negatively Regulated
by Phosphorylation In Vivo?is localized to centrosomes and chromosomes, disap-
pears (Clute and Pines, 1999). In this respect we note It has been shown that overexpression of nondegrad-
able cyclinB1 in mammalian cells causes a metaphasethat (1) separase also localizes to the centrosomes (H.Z.,
O.S., and M.W.K., unpublished data; D. Pellman, per- arrest (Clute and Pines, 1999; J. Hoyt and R. King, per-
sonal communication). This demonstrates that nonde-sonal communication) and that (2) cohesin, which speci-
fies the place of separase’s ultimate action, is bound to gradable cyclinB1 can block anaphase not only in vitro
but also in vivo. We asked whether this mechanismchromosomes. Therefore, the early relocalization/deg-
radation of cyclinB1 occurs at the right time and at the might also operate under physiological conditions by
measuring the in vivo phosphorylation of separase atright place to support a model in which a local drop of
CDC2 activity causes a local activation of separase. its inhibitory site. To this end, we have employed a quan-
titative mass spectrometry method that can measureSuch a localized activation might also explain why we
Cell
724
the level of phosphorylation from total cell extracts. The Recent studies have provided strong additional evi-
dence for the existence of a securin-independent mech-inhibitory site is fully phosphorylated in nocodazole-
anism controlling anaphase in vertebrates. Securinarrested HeLaS3 cells that do not overexpress cyclinB1.
knockout mice are viable and fertile, and exhibit only aFurthermore, the phosphorylation state at this site drops
moderate phenotype (Mei et al., 2001; Wang et al., 2001).markedly upon anaphase onset, thereby strongly im-
Careful examination of human cells that do not expressplying that the discovered inhibition mechanism oper-
securin revealed that chromosomes are lost with higherates in dividing somatic cells.
frequency (Jallepalli et al., 2001). Nevertheless, these
cells remain viable, demonstrating that the regulationWhat Is the Kinase that Inhibits Separase?
of sister chromatid separation is at least partially intact.The phosphorylated residue of both inhibitory sites of
Furthermore, the securin-depleted cells—in contrast toseparase is followed by a proline. Therefore, both sites
yeast—still arrest at metaphase in response to spindlematch the consensus sequence typical of CDC2 and
toxins (Jallepalli et al., 2001). For human separase, weMAPK substrates. Likewise, both CDC2/cyclinB1 and
have shown that the binding of securin and phosphoryla-MAPK (ERK2) efficiently phosphorylate separase at its
tion can occur independently of each other. Moreover,major inhibitory site in vitro. Although all our results are
the inhibitory phosphorylation at Ser1126 is in placefully consistent with CDC2/cyclinB1 acting on separase
in nocodazole-arrested cells. Therefore, these resultsdirectly, we cannot exclude MAPK as a downstream
provide a plausible explanation for the regulated ana-mediator. It has been shown that MAPK can be activated
phase onset in securin-depleted cells as well as for theirdownstream of CDC2/cyclinB1 in Xenopus egg extract
checkpoint competence.(Guadagno and Ferrell, 1998). Furthermore, MAPK is
activated in mitosis and is required for the spindle as-
Is the Negative Regulation of Separasesembly checkpoint in the Xenopus system as well as in
by Phosphorylation Conserved?somatic cells (Minshull et al., 1994; Shapiro et al., 1998;
The regions surrounding the inhibitory phosphorylationWang et al., 1997; Zecevic et al., 1998). It will therefore
sites in human separase (Ser1126 and Thr1346) are con-be interesting to ask whether CDC2/cyclinB1 is able to
served in mouse separase (Celera mCP9586) but showinhibit anaphase in the absence of MAPK and/or whether
no significant homology to any other protein in the data-MAPK can cause inhibition of sister chromatid separa-
base. Outside the conserved C-terminal domain, thetion independent of CDC2/cyclinB1. In Xenopus ex-
separase sequence of other organisms is either nottracts, MAPK activity drops with a delay of about 10
known (vertebrates other than mammals) or shows littlemin relative to the decrease of CDC2/cyclinB1 activity
homology to human and mouse separase (fungi, plants,(Minshull et al., 1994; Takenaka et al. 1997; Guadagno
insects, and nematodes). Nonetheless, we still thinkand Ferrell, 1998). It is therefore possible that the inhibi-
that, at least in vertebrates, the negative regulation oftory phosphorylation of separase is sustained by MAPK
separase by phosphorylation is conserved. This is basedfor some time even after CDC2/cyclinB1 levels have
on the finding that human PM-2 is sufficient to rescuebegun to drop. Such a model might help to explain the
separation of Xenopus chromosomes in high-90 ex-fact that anaphase commences only about 25 min after
tract, thus demonstrating that in frogs, separase is alsothe mitotic checkpoint is inactivated and degradation
inhibited by phosphorylation (O.S., H.Z., and M.W.K.,of cyclinB1 is detectable (Rieder et al., 1994; Clute and
unpublished data).Pines, 1999).
The lack of obvious sequence conservation does not
For the other kinases tested, our experiments pro-
in itself exclude the possibility that the separases of
vided a more definite answer. Polo, auroraA, and CaMKII
fungi, plants, insects, and nematodes might also be reg-
were unable to phosphorylate Ser1126 of separase in ulated by phosphorylation. For example, lack of the
vitro. Furthermore, in vivo, the phosphorylation status S-phase cyclins CLB5 and CLB6 in budding yeast by-
of Ser1126 is low in S-phase when the cyclinA2 level is passes the requirement of securin degradation for ana-
high (Figure 6). These results lead us to conclude that phase but not of cohesin cleavage (Meyn and Holloway,
Polo, auroraA, CaMKII, and CDK2/cyclinA are unable to 2000). This observation suggests that these cyclins
inhibit separase, at least not via phosphorylation of the might be required to downregulate separase activity in S
major inhibitory site that we have identified. phase, possibly to allow the establishment of chromatid
cohesion. Similarly, Drosophila cyclinA negatively regu-
Evidence for Securin-Independent Regulation lates sister chromatid separation but does not interfere
of Anaphase with the degradation of PIM (the fly securin), suggesting
Yeast cells lacking securin (Pds1) still separate sister that CDC2/cyclinA might be able to inhibit separase
chromatids in a regulated manner, but they fail to block in this organism (Foley and Sprenger, 2001; Parry and
anaphase in response to nocodazole. Based on this O’Farrell, 2001; Sigrist et al., 1995). While different ki-
result, it was proposed that anaphase onset must be nases might inhibit separase, the basic dual inhibition
controlled by an additional regulatory mechanism that model for sister chromatid separation may be applicable
does not require securin. Such a mechanism has re- to several phyla.
cently been discovered by Nasmyth and coworkers, who
Experimental Proceduresfound that polo/Cdc5 kinase promotes sister chromatid
separation by phosphorylation of Scc1 at serine resi-
Expression Constructs, Recombinant Proteins,
dues close to its cleavage sites (Alexandru et al., 2001). and Antibodies
However, the phosphorylation sites are not conserved Full-length human separase was PCR-amplified from a human fetal
thymus cDNA library (Clontech) using the following primers: 5-ATGin human SCC1.
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AGGAGCTTCAAAAGAGTCAACTTTGGGAC-3 and 5-TTACCGCA Mass Spectrometry
Coomassie stained securin and separase bands were digested in-GAGAGACAGGCAAGCC-3. Human cohesinhSCC1 was isolated from
the same library using a different set of primers (5-ATGTTCTA gel (Shevchenko et al., 1996). Extracted peptides were separated by
nano-scale microcapillary high performance liquid chromatographyCGCACATTTTGTTCTCAG-3 and 5-TATAATATGGAACCTTGGTC
CAGGTG-3). Both separase and securin were subcloned into the (HPLC) as described (Gygi et al., 1999). Eluting peptides were ionized
by electrospray ionization and analyzed by an LCQ-DECA ion trapmulti-purpose expression vector pCS2 (various versions). The re-
sulting plasmids were utilized for transfection into 293T cells and mass spectrometer (ThermoFinnigan). Peptide ions reaching a cer-
tain threshold were automatically selected for sequence analysisfor in vitro expression in TNT reticulocyte lysate (Promega). For
immunoprecipitation of separase, two types of N-terminal tags were by tandem mass spectrometry. Peptide sequence was determined
by data-searching against the nonredundant human protein data-fused to the amino terminus of separase, three HA tags (Figure 2A),
or two IgG binding domains of protein A, followed by four TEV- base using the Sequest algorithm (Eng et al., 1994).
The phosphorylation analysis of separase will be described else-protease cleavage sequences (ZZ-TEV4-tag; Figures 2B, 4B, 5, 6D–
6E, and 7). Both versions of separase gave essentially the same where (S.A.G. and S.P.G., unpublished data).
results. Site directed mutagenesis was performed using either the
QuickChange kit (Stratagene) or the GeneEditor system (Promega). Sister Chromatid Separation and Segregation
All mutations were confirmed by DNA sequencing of manipulated in Xenopus Egg Extracts
regions. CSF extracts were prepared as described (Murray, 1991). For sister
His-tagged human cyclinB190 and recombinant securin were chromatid separation assays, two sources of chromosomes were
prepared as described (Kumagai and Dunphy, 1991; Zou et al., used: Xenopus sperm nuclei and isolated human metaphase chro-
1999). The separase and hSCC1 antibodies were raised against an mosomes. Xenopus sperm nuclei were prepared as described by
N-terminal peptide (RSFKRVNFGTLLSSQ) and a C-terminal peptide Philpott et al. (1991). When they were used, the protocol developed
(EPYSDIIATPGPRFH), respectively (Genemed Synthesis). The anti- by Murray and colleagues was followed (Holloway et al., 1993), with
securin antibody was described elsewhere (Zou et al., 1999). the exception that 90 was usually added later, about 50 min after
CSF. Reisolation of Xenopus chromosomes was done according to
Funabiki and Murray (2000). When human chromosomes were used,
Separase Activity and Kinase Assays the KCl concentration was lowered to 70 mM. 90 and isolated
To obtain securin/separase complexes, 293T cells were cotrans- securin/separase (0.1 volumes) were added 20 min after addition
fected with separase and securin expression plasmids using a cal- of human chromosomes. After additional 20 min at 20C, Ca2 (0.6
cium phosphate-based method and subsequently synchronized as mM) was added. Chromosomes were reisolated from extracts 50
described (Fang et al., 1998). Two days after transfection, the noco- min thereafter. Analysis by immunofluorescence microscopy was
dazole-arrested cells were lysed in 20 mM Tris/HCl (pH 7.7), 100 done as described (Wood et al., 1997). The percentage of separated
mM NaCl, 1 mM NaF, 20 mM -glycerophosphate, 5 mM MgCl2, chromosomes was calculated according to the following equation:
0.1% Triton X100, and 1M microcystin-LR. After ultracentrifugation % separation (number of single chromatids/2) / ([number of single
at 100,000 	 g, the supernatant was mixed with anti-HA agarose chromatids/2]  number of unseparated chromosomes).
(3F10, Roche) or IgG-sepharose (Amersham), depending on the tag
of separase. For a 10 cm dish of confluent, transfected cells (corre-
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